A real-world assessment of tolerability and treatment outcomes of COVID-19 monoclonal antibodies administered in pregnancy

Am J Obstet Gynecol. 2022 May;226(5):743-745. doi: 10.1016/j.ajog.2022.01.018. Epub 2022 Jan 21.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents, Immunological* / therapeutic use
  • COVID-19*
  • Female
  • Humans
  • Migraine Disorders* / drug therapy
  • Pregnancy
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents, Immunological